Submitted by Anonymous (not verified) on 29 September 2023 - 15:19
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Waldenstrom Macroglobulinemia, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised
Source: